This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...

Southeast Asia Medical Wearable Devices Market was valued at ~USD 2,080.65 million in 2024 grow at a strong CAGR of ...

In general, as someone without diabetes, you want your fasting blood sugar (when you haven’t eaten for at least eight hours) to be below 100 mg/dL. You want your spikes to be below 180 mg/dL, to lower ...

DexCom Inc (NASDAQ:DXCM) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. As of the ...

The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

Need the Latest HME News in the Industry? Want to always have the latest HME news in the industry right in your inbox? Click the button below to subscribe.

While I can see most gamers or professional esports players using the monitor at the native resolution at up to 600Hz, I am having a hard time imagining a scenario where the 1,040Hz refresh rate ...

Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, aimed at adults who are not using insulin but still want detailed glucose ...

On March 25, 2025, the FDA published the Warning Letter on its website, revealing that DexCom had “adulterated” its G6 and G7 glucose monitors by “modifying the G6 and G7 sensors” without prior ...

Patients with type 2 diabetes demonstrated improved glycemic control with the use of automated insulin delivery regardless of baseline C-peptide levels. Automated insulin delivery (AID) systems should ...